Effect of arterioportal shunting in radical resection of hilar cholangiocarcinoma

来源 :中华医学杂志英文版 | 被引量 : 0次 | 上传用户:haiyang1979
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background The resection and reconstruction of the hepatic artery is often required in radical surgery for hilar cholangiocarcinoma. In this study, we report our experience in performing arterioportal shunting as an altative for the arterial reconstruction.Methods Four patients with hilar cholangiocarcinoma underwent extended left hepatectomy and caudate Iobectomy combined with en bloc resection of the hepatic artery and arterioportal shunting with restriction of the arterial caliber. The efficacy of arterioportal shunting was assessed by computed tomography angiography (CTA).Results All the four patients recovered uneventfully without any complications. CTA showed a patent shunt and normal liver regeneration. No signs of portal hypertension were found at one year of follow-up.Conclusions Arterioportal shunting with restriction of the arterial caliber appears to be a feasible and safe altative for the microvascular reconstruction after hepatic artery resection in radical surgery for hilar cholangiocarcinoma.
其他文献
Background Recent studies have identified signal transducer and activator of transcription 4 (STAT4) as a susceptibility gene for systemic lupus erythematosus (
通过调整靛红与石灰的投料比例,减少了氯丙酮的用量,降低了生产成本.
本文通过对纸浆的分步染色的方法,从而达到染制深色的目的.
测试平台模拟真实轨道设计,配有不同波长及波幅的可更换式轨面波形模拟条,满足动态钢轨平直度测量仪针对被测钢轨几种典型不平顺类型的测量需求。测试平台基于计量原理设计,
本文主要介绍了蒽醌染料的光氧化和光还原褪色机理及其规律,同时详细分析了影响染料光褪色的各种因素,并提出了解决光褪色问题的一些途径.
目的探讨胸部外伤的诊断与外科的治疗方法。方法回顾性分析我院的胸部外伤患者197例的临床外科治疗,其中行胸腔闭式引流143例,剖胸手术42例,手术治疗占同期胸部外伤的26·5%
动车联络线小半径曲线严重的侧磨对动车运行安全有着极不利的影响,结合现场调研及相关理论研究,提出四种减磨措施,并对实际线路进行改造。安全性及后期磨耗效果分析结果表明,
目的探讨盆底超声诊断压力性尿失禁(SUI)的超声指标、诊断标准及诊断价值。方法应用单因素logistic回归比较260例SUI患者与60例正常女性盆底超声参数的差异,寻找其相关诊断指标,采用ROC曲线评估其诊断标准及诊断价值。结果两组患者静息状态时尿道倾斜角、肛提肌裂孔面积以及Valsalva动作时膀胱颈位置、膀胱位置、尿道倾斜角、膀胱尿道后角、肛提肌裂孔面积、膀胱颈移动度及尿道旋转角比较差异均有
本文综述了偶氮缩合颜料的品种、性能、制备方法以及应用
Background Dual anti-platelet treatment with aspirin and clopidogrel is established foundation for patients undergoing percutaneous coronary intervention (PCI)